About this item:

252 Views | 158 Downloads

Author Notes:

Address correspondence to: Bargavi Thyagarajan, Global HIV Vaccine Enterprise, 64 Beaver Street No. 352, New York, NY 10004, E-mail: bthyagarajan@vaccineenterprise.org

Conference Co-Chairs for HIVR4P 2016 were Thomas Hope (Northwestern University), Jeanne Marrazzo (University of Alabama at Birmingham), Lynn Morris (South African National Institute for Communicable Diseases), and Nelly Mugo (Kenya Medical Research Institute).

Conference partners for HIVR4P 2016 included the French National Agency for Research on AIDS and Viral Hepatitis (ANRS); Bill and Melinda Gates Foundation; CAPRISA; Gilead Sciences; GSK; the International AIDS Vaccine Initiative (IAVI); International Partnership for Microbicides (IPM); Janssen; National Institutes of Health (NIH); NIH Office of AIDS Research (OAR); PEPFAR; Population Council; Sanofi Pasteur; South African Medical Research Council; USAID; and ViiV Healthcare.

The authors acknowledge the conference participants who agreed to release the contents of their presentations.

They apologize to all those whose important work could not be cited in this review due to space limitations.

The views expressed herein do not necessarily reflect the official views or policies of partners.

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services or USAID, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

No competing financial interests exist.

Subjects:

Research Funding:

Significant in-kind support was provided by AVAC: Global Advocacy for HIV Prevention; Global HIV Vaccine Enterprise; Kenya Medical Research Institute; University of Alabama at Birmingham; the National Institute for Communicable Diseases; and Northwestern University.

HIVR4P 2016 was made possible, in part, by the support of the American people through 1 R13 AI122959-01 from the National Institute of Allergy and Infectious Diseases (NIAID), and from the United States Agency for International Development (USAID).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Immunology
  • Infectious Diseases
  • Virology
  • HIV prevention
  • microbicide
  • vaccine
  • PrEP
  • R4P
  • antibody
  • MALE CIRCUMCISION
  • UGANDA
  • TRIAL
  • RAKAI
  • MEN

HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights

Show all authors Show less authors

Tools:

Journal Title:

AIDS Research and Human Retroviruses

Volume:

Volume 33, Number 8

Publisher:

, Pages 749-759

Type of Work:

Article | Final Publisher PDF

Abstract:

HIV Research for Prevention: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P) was built on a growing consensus that effective HIV prevention requires a combination of approaches and that understanding, analyzing, and debating the cross-cutting issues that impact prevention research are all essential to combat the global HIV/AIDS epidemic. To that end, the biennial HIVR4P conference is dedicated to all biomedical HIV prevention research approaches, including HIV vaccines, microbicides, pre-exposure prophylaxis, and treatment as prevention. The HIVR4P 2016 conference was held in Chicago, Illinois (USA), on October 17-21, and included more than 700 scientific presentations and 21 satellite sessions covering the latest and most promising advances across the HIV prevention research field. The theme "Partnering for Prevention" represented the conference's commitment to breaking down silos between research disciplines as well as between researchers, program developers, care providers, advocates, communities, and funders. Delegates spanning 42 countries attended the conference. One-third of those in attendance were early career investigators, which reflects a firm commitment to emerging researchers and ultimately to the goal of developing a sustainable scientific enterprise well into the future. This article presents a concise summary of highlights from the conference. For a more detailed account, one may find full abstracts, daily summaries, and webcasts on the conference website at hivr4p.org.

Copyright information:

© 2017 Barbara L. Shacklett t al.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote